1. Scrip
  2. >>Focus On Asia

Catchup Capsule: Key APAC Insights You Need To Read

 
• By Ian Haydock

Given its ever-growing role as a critical region for the global biopharma industry, you can’t afford not to be up to speed on Asia. This selection of recent insights from our experienced on-the-ground team will help.

mumbai skyline
Executives from Mumbai-based Sun Pharma were among Scrip's recent interviewees • Source: Alamy

A selection of key stories and an audio interview from the past few weeks from the Asia-based content team for Scrip and the Pink Sheet, reflecting the diversity and depth of issues facing the biopharma industry in this critical and fast-changing region.

In this edition: an interview with senior executives at India's largest pharma firm; China tightens accounting rules; a Korean venture...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Focus On Asia

More from Scrip

Bayer Bags First Global Okay For Hot Flashes Therapy

 
• By Kevin Grogan

Lynkuet will compete with Astellas's Veozah/Veoza

China’s Biotechs Were The Small-Cap Rising Stars In H1 2025

 
• By Andrew McConaghie

The list of small-cap companies with the fastest-rising share prices so far this year is dominated by Chinese companies, underscoring their growing contribution to the global biopharma ecosystem.

In Brief: Soleno To Raise $200m To Boost Vykat XR Launch

 
• By Manas Mishra

Soleno Therapeutics will raise about $200m gross proceeds from an offering of 2.35m of its common stock to fund the commercialization of Vykat XR, which became the first drug for Prader-Willi syndrome to gain US approval on March 26.